TFAP2A and TFAP2C was associated with worse clinical stage and prognosis in BLCA patients, while TFAP2B, TFAP2D and TFAP2E showed the opposite trend. The gene discussed is TFAP2D; the disease is bladder transitional cell carcinoma.